Posted by Maury from IP 75.74.59.201 on April 27, 2007 at 08:55:14:
In Reply to: Q posted by img on April 26, 2007 at 10:10:09:
the answer is a, headache is maybe secondary, The complications caused by beta-mimetic therapy are Respiratory distress, tachycardia, hyperglycemia and chestpain. Because intravenous beta-mimetic drugs can cause severe hypotension and tachycardia, the patient's blood pressure should be monitored frequently. Myocardial ischemia is also associated with intravenous administration of ritodrine; therapy should be discontinued and an electrocardiogram should be obtained immediately if the patient has chest pain or develops an arrhythmia. Pulmonary edema can be avoided by limiting the sodium and total fluid load to a maximum of 2,500 to 3,000 mL per 24 hours. Fluid input and output, daily weight, hourly respiratory rate and signs of pulmonary fluid accumulation should be monitored. Because hyperglycemia and ketoacidosis have occurred in patients receiving beta-mimetic therapy, serum glucose should be measured at baseline and repeated at 12-hour intervals in a patient without diabetes and at two-hour intervals in a patient with diabetes who is receiving intravenous fluids. Metabolic alterations, hypoglycemia or cardiac arrhythmias, and hypokalemia should be treated appropriately.